This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, Y. Articles by Lance, P. Search for Related Content PubMed PubMed Citation Articles by Zhu, Y. Articles by Lance, P.

Cyclooxygenase-2 Expression and Prostanoid Biogenesis Reflect Clinical Phenotype in Human Colorectal Fibroblast Strains¹

Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 [Y. Z., P. L.], and Department of Physiology and Biophysics, University at Buffalo, Buffalo, New York 14214 [P. H.]

Up-regulated cyclooxygenase (COX)-2 expression and prostaglandin E₂ (PGE₂)synthesis contribute causally to the early stages of colorectal neoplasia and carcinogenesis, yet COX-2 expression is barely detectable in normal and premalignant colorectal epithelium. Rather, COX-2 expression in nonmalignant colonic tissue is probably confined to subepithelial cells, such as fibroblasts. We established a panel of 33 primary subepithelial fibroblast strains from human colonoscopic biopsies of normal colon (group I), normal segments of colons that harbored synchronous advanced neoplasms in remote segments (group II), advanced neoplasms (group III), and segments of active ulcerative colitis (group IV). In group I strains, mean basal and peak PGE₂ levels after 24 h of interleukin (IL)-1ß stimulation were 5.4 ± 1.1 and 32.8 ± 4.9 ng/mg protein, respectively. Mean IL-1ß-stimulated peak levels in groups II, III, and IV strains were, respectively, 6-, 9-, and 7-fold greater than that in group I (P < 0.001 for each comparison), and inductions of COX-2 mRNA and protein were consistent with these findings. IL-1ß-mediated stimulation of PGE₂ was fully blocked in the presence of a nonselective COX inhibitor (indomethacin) or a selective COX-2 inhibitor (NS-398). IL-1ß treatment elicited from group I (normal) and group III (cancer-associated) fibroblasts, respectively, 2- and 3-fold inductions of COX-2 transcriptional activity and 1.4- and 1.7-fold inductions of COX-2 promoter activity. This modestly greater COX-2 transcription rate could not alone account for the dramatically higher levels of COX-2 mRNA and protein and PGE₂ in cancer-associated compared with normal fibroblasts. However, incubation of fibroblasts with PGE₂ after IL-1ß stimulation prolonged COX-2 mRNA half-life from 1 to 9 h. Our results strengthen the evidence that fibroblasts and other mesenchymal cells are the source of COX-2 expression in normal and premalignant colorectal tissue. Group II fibroblasts from normal segments of colons that harbored synchronous remote advanced neoplasms behaved like group III fibroblasts from advanced neoplasms and not group I fibroblasts from normal colons. We hypothesize that the effects of modestly greater COX-2 transcription in groups II–IV fibroblasts yield corresponding modest increases in PGE₂ synthesis whose effects are progressively amplified through robust stabilization of COX-2 mRNA.

This article has been cited by other articles:

				J. M. Little, M. Kurkela, J. Sonka, S. Jantti, R. Ketola, S. Bratton, M. Finel, and A. Radominska-Pandya Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases J. Lipid Res., September 1, 2004; 45(9): 1694 - 1703. [Abstract] [Full Text] [PDF]